BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 27
• 28
• 29

• Biotech Beach

  Eli Lilly and Company Oncology Reveals Findings From Study of JAK2 Inhibitor for Blood Cancers at American Society of Hematology Meeting

  December 12, 2011

   · 

  7 min read
• Biotech Bay

  Kaiser Permanente Study Finds no Elevated Risk of Serious Cardiovascular Events Associated with use of ADHD Medications in Young and Middle-aged Adults

  December 12, 2011

   · 

  5 min read
• Biotech Bay

  Genomic Health, Inc. Announces Results from Fourteen Studies Emphasizing Belief of Physicians around the World in the Value of Oncotype DX

  December 12, 2011

   · 

  9 min read
• Deals

  ICON Acquires BeijingWits Medical Consulting Ltd

  December 12, 2011

   · 

  1 min read
• Drug Development

  CytRx Corporation Announces the Presentation of Favorable Phase 2 Clinical Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia at American Society of Hematology Conference

  December 12, 2011

   · 

  1 min read
• Deals

  Laboratory Corporation of America Holdings (LabCorp) Successfully Completes Tender Offer for Orchid Cellmark and Commences Subsequent Offering Period to Allow for Additional Tenders

  December 12, 2011

   · 

  1 min read
• ExonHit Therapeutics Inc.: AclarusDx®: Launch of Observational Study in France

  December 12, 2011

   · 

  1 min read
• Drug Development

  Seattle Genetics, Inc. Reports Data From Multiple Presentations on ADCETRIS™ (Brentuximab Vedotin) at American Society of Hematology Annual Meeting

  December 12, 2011

   · 

  1 min read
• Drug Development

  Avila Therapeutics Presents Data on AVL-292, a Selective Bruton’s Tyrosine Kinase Inhibitor, for the Treatment of B Cell Cancers at the 2011 American Society of Hematology Annual Meeting

  December 12, 2011

   · 

  1 min read
• Business

  Napo Pharmaceuticals, Inc. Terminates Glenmark Pharmaceuticals for Failure to Commercially Develop Crofelemer

  December 12, 2011

   · 

  3 min read